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Effects of rhythmic sensory stimulation (auditory, visual) on gait 
in Parkinson’s disease patients 
Pablo Arias, Javier Cudeiro 
Abstract. This study has focused on how sensory stimulation affects gait in Parkinson’s disease (PD). 
The kinematic parameters of gait [cadence, step amplitude, velocity, coefficient of variation of stride time 
(CVstride-time), and the coefficient of variation of the step amplitude (CVstep-amplitude)] were analysed in 25 
PD patients and 10 control subjects. Step amplitude, velocity and CVstride-time were altered in the patients 
with PD. However, when kinematic parameters were analysed as a function of disease severity, none of 
the parameters differed between early PD (I–II Hoehn and Yahr) and the controls. Nevertheless, more 
severely affected PD patients (III–IV Hoehn and Yahr) walked with a reduced step amplitude, lower 
velocity, higher CVstride-time, and higher CVstep-amplitude than the controls. The administration of auditory 
stimulation at a frequency matching the preferred walking cadence led to a decrease in the CVstride-time in 
PDIII–IV patients, and to an increase in step amplitude in PDIII–IV and controls. Visual stimulation at the 
same frequency did not modify any of the altered kinematic parameters in PDIII–IV patients. When 
different stimulation frequencies were utilised, auditory stimulation significantly changed some of the 
altered walking parameters in Parkinson patients. Frequencies matching preferred walking cadence or 
above this, up to the fastest walking, were those that seem to interact most effectively with the abnormal 
kinematic parameters in PDIII–IV patients. Visual stimulation negatively modulated cadence in PDIII–IV in 
the frequency range used. Sensory stimulation facilitates gait in PD. Studies using sensory stimulation as 
a tool to facilitate walking should take into account the grade of disability of the patients. 
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Introduction 
The gait of patients suffering from PD is characterized by the alteration of different spatio-temporal 
parameters. One of these alterations is a shorter step/stride length compared to control subjects, which is 
responsible for the decreased velocity manifested by these patients (Blin et al. 1990; Morris et 
al. 1994a, 1996, 2005; Thaut et al. 1996; Azulay et al. 1999; Ebersbach et al. 1999; Lewis et al. 2000; 
Frenkel-Toledo et al. 2005; Fernández del Olmo and Cudeiro 2005; Rochester et al. 2005; Willems et 
al. 2006). Coefficient of variation (CV) of stride length is also thought to increase (Blin et al. 1990; Lewis 
et al. 2000). While the shorter stride is considered the main feature of the Parkinsonian gait (Morris et 
al. 1994a, b, 1998), alterations in cadence seem to be more controversial. While several studies have 
shown that cadence remains unaltered in PD (Morris et al. 1994a, 1998, 2005; Hausdorff et al. 1998; 
Lewis et al. 2000; Fernández del Olmo and Cudeiro 2005; Rochester et al. 2005; Frenkel-Toledo et 
al. 2005) others have detected a reduction in cadence (Blin et al. 1990; Thaut et al. 1996; Azulay et 
al. 1999; Ebersbach et al. 1999; Willems et al. 2006). A high coefficient of variation for the stride cycle 
time (CVstride-time) is also an important feature of PD gait (Hausdorff et al. 1998; Fernández del Olmo and 
Cudeiro 2005), as it is considered an indicator of the risk of suffering from falls (Schaafsma et al. 2003). 
The PD is a progressive disease in which the alterations in gait vary according to the severity of the 
disease (Goetz et al. 2004). Thus, when characterizing PD gait it is necessary to take into account the 
phase in which the patients are at the time of analysis, which has not always been the case. 
Previous studies have shown that the utilization of rhythmic sensory cues facilitates walking in PD 
and that PD patients walk better in the presence of rhythmic auditory cues (Enzensberger and 
Fischer 1996; McIntosh et al. 1997; Howe et al. 2003). While some studies have focused on the effect of 
auditory stimulation at a frequency matching preferred walking cadence (PW-cadence) (Freedland et 
al. 2002; Rochester et al. 2005; Willems et al. 2006), others have used different stimulation frequencies 
(Enzensberger and Fischer 1996; McIntosh et al. 1997; Ebersbach et al. 1999; Freedland et al. 2002; 
Howe et al. 2003; Willems et al. 2006), with baseline condition (PW or fastest-walking—FW) differing 
between studies. The observed improvement in performance is manifested by the modification of 
parameters such as amplitude or velocity, and is seen with frequencies higher than PW-cadence. Despite 
these improvements, attempts to use stimulation protocols which search across a range of frequencies in 
order to identify the best stimulation parameters to be used, are scarce, [however, see Willems et al. 
(2006) and Howe et al. (2003)]. 
Visual stimulation has also been used in order to improve the walking pattern of PD patients. 
Traditionally, visual stimuli were provided by means of a series of stripes laid out on the floor for the 
patients to walk over. This kind of stimulation has been shown to improve stride amplitude (Morris et 
al. 1994a, 1996, 2005; Azulay et al. 1999; Lewis et al. 2000; Suteerawattananon et al. 2004), velocity 
(Morris et al. 1996, 2005; Azulay et al. 1999; Lewis et al. 2000) and the CV of stride amplitude (Lewis et 
al. 2000). However, this type of stimulation is not practical to apply outside of a controlled environment, 
despite the efforts made by Lewis et al. (2000). Recently, rhythmic visual stimulation has been proposed 
provided by light emitting diode’s (LED) integrated in a pair of goggles (Rochester et al. 2005). 
In addition, some studies have focused on the potential of training paradigms, particularly using 
auditory stimuli, in which patients improve gait, and in some cases, make long-lasting improvement 
(Miller et al. 1996; Thaut et al. 1996; Marchese et al. 2000; Fernández del Olmo and Cudeiro 2005; 
Fernández del Olmo et al. 2006; Nieuwboer et al. 2007). 
However, the studies using auditory and visual stimulation carried out to date have not taken into 
account the grade of the disability of the patients. The work reported here forms part of a series of studies 
investigating both auditory and visual sensory stimulation in PD patients. The aim of the work was 
threefold: (1) to characterize Preferred Walking gait in PD patients and to determine the differences 
according to the grade of development of the disease; (2) to identify the effect of external sensory cues 
(auditory, visual, and auditory–visual) on the performance of those patients suffering from significant 
alterations in their walking pattern; (3) to test the effect of applying sensory stimuli at different 
frequencies in order to determine which frequency produces the best results, with a view to optimizing 
stimulation strategies for future rehabilitation paradigms. For aim (2), stimulation frequency was set at a 
rate that matched the cadence of each subject during their PW. In this protocol any change in the walking 
pattern would therefore be attributable to the presence of the stimulus, not to its frequency, since it 
matched the PW cadence. For aim (3), two groups of auditory and visual stimulation frequencies were 
established, optimizing the range to each individual’s cadence in the walking test at their fastest speed in 
the absence of stimulation. 
Methods 
Subjects 
Patients 
The patients were recruited from the Parkinson’s Disease Association of Galicia (Table 1) and 
evaluated from October to December 2005. The study was carried out on 25 idiopathic PD patients 
(Table 2). In order to take into consideration disease severity when analyzing the data, the whole group 
was divided into two groups, mild and severe patients. The mild PD group (n = 16) comprised 16 patients 
in phases I or II according to the Hoehn and Yahr (1967) evaluation scale (PDI–II). The group of severe 
patients (n = 9) included patients considered as phase III or IV patients (PDIII–IV) and these PDIII–IV 
patients, were those who participated in the experiments in which the effects of sensory stimulation were 
assessed.  
Prior to the experiment, all patients were examined by a neurologist (who was unaware of the nature 
of the experiment) using a battery of tests including: the short test of mental status (STMS, Kokmen et 
al. 1987); UPDRS (Fahn and Elton 1987); Hoehn and Yahr (1967); and Schwab and England (1969) 
scales. Patients were excluded from the study if they displayed any of the following features: 
Neurological disease other than PD; musculoskeletal, cardiovascular, auditory or visual impairment; 
inability to walk for 30 m; STMS score <30. 
Evaluation was carried out while patients were on-dose and the session lasted no more than 1 h to 
avoid the effects of the medication wearing-off. Tests started about 45 min after morning dose intake.  
Table 1. Trial flow-chart 
Assessed for eligibility 
Controls (n = 10)–PD (n = 37) 
Allocation  Excluded: 12 PD 
(Controls, n = 10) Allocation to intervention (PD, n = 25) Not meeting inclusion criteria: 
(Controls, n = 10) Received allocated intervention (PD, n = 25) 4: <30 STMS 
(Controls, n = 0) Did not receive allocated intervention (PD, n = 0) 1: Hip Prosthesis 
3: Arthritis. 
3: Visual impairment (1 Glaucoma, 2 Cataract)  
Refused to participate: 0 
Other reason: 1 (feeling sick the day of the experiment) 
 
Analysis  
(Controls, n = 10) Analysed (PD, n = 25)  
(Controls, n = 0) Excluded from analysis (PD, n = 0)  
 
Table 2. Patient’s characteristics 
Patients Sex Age Tro height (m) Years diag. H&Y S&E UPDRS 
        
M.A.L M 51 0.89 2 1 90 12 
RMª.G.P F 59 0.90 5 1.5 90 38 
C.P.M F 70 0.85 2 2 80 32 
C.S.R M 66 0.87 5 2 80 38 
JMª.G.R M 69 0.80 5 2 80 25 
M.G.A F 58 0.86 3 2 80 20 
R.R.C M 55 0.87 3 2 80 29 
D.R.M F 70 0.84 13 2.5 70 47 
E.G.N M 76 0.89 6 2.5 70 48 
E.S.S F 62 0.82 7 2.5 80 33 
MªL.M.F F 55 0.83 12 2.5 70 65 
J.E.L M 70 0.88 10 2.5 80 58 
J.M.P M 66 0.85 3 2.5 80 52 
J.V.P M 71 0.89 18 2.5 70 33 
JA.V.B M 55 0.85 10 2.5 60 70 
V.S.R  M 53 0.99 4 2.5 60 69 
JMª.P.G M 66 0.89 9 3 60 68 
C.V.L M 71 0.84 8 3 50 78 
J.C.I F 75 0.82 20 3 40 82 
M.T.C M 69 0.98 7 3 40 75 
Mª.G.A F 73 0.81 6 3 50 64 
Mª.M.M.S F 71 0.80 7 3 60 73 
G.P.V F 74 0.81 23 3 50 70 
J.C M 68 0.86 14 3 40 72 
A.M.G M 75 0.84 22 4 20 84 
    Mean  Mean  Mean  Mean  Mean  Mean  
PD (n = 25)   65.92 (±7.65) 0.86 (±0.04) 8.96 (±6.22) 2.52 (±0.60) 65.20 (±18.06) 53.40 (±21.31) 
PDI–II  (n = 16)   62.88 (±7.80) 0.87 (±0.04) 6.75 (±4.61) 2.19 (±0.44) 76.25 (±8.85) 41.81 (±17.50) 
PDIII–IV (n = 9)   71.33 (±3.20) 0.85 (±0.06) 12.89 (±7.01) 3.11 (±0.33) 45.56(±12.36) 74.00 (±6.50) 
        
 
Control subjects 
Ten healthy subjects were recruited as the control group. There were no significant differences in age 
(65.70 years ± 7.65) and trochantereal height (0.86 m ± 0.05) between PD patients and controls. In the 
experiments to assess the effects of sensory stimulation, nine of the healthy subjects were sub-selected as 
controls whose age and trochanteral height did not differ from those of the PDIII–IV group. 
Subjects were informed about the nature of the test. The protocol was in compliance with the Helsinki 
declaration and it was approved by the University of A Coruña Ethics Committee.  
Procedure 
Characterization of gait pattern 
In the first instance, this study set out to characterize the gait pattern in a population of PD patients 
and to compare this with the gait displayed by control subjects. 
In order to establish the gait patterns in controls and PD patients, subjects were required to walk along 
a 30 m level walkway using their preferred walking pattern. Recordings were acquired from the central 
25 m, disregarding the 2.5 m at the beginning and at the end of the walkway to minimize the effect of 
acceleration and deceleration. The instruction given to the subjects was “Walk to the end of the corridor 
as you normally do”. 
Stimulation at a frequency matching PW-cadence 
Subsequently, we investigated the use of sensory rhythmic stimulation as a tool to facilitate walking in 
PD patients. Utilising the results of our first study, this kind of stimulation was only used with those 
patients who suffered a significant alteration in gait and we used only frequencies of stimulation, which 
matched the normal cadence of each patient. 
The subjects were required to walk along the same walkway used before in presence of stimulation at 
a frequency matching each subject’s PW-cadence. Three kinds of stimuli were presented in 
counterbalanced way: auditory (PWA); visual (PWV); and auditory–visual (PWAV). 
Utilization of different stimulation frequencies 
Finally, we introduced different stimulation frequencies in order to identify the best frequencies to be 
used. Subjects were required to walk along the same walkway first in the absence and then in the presence 
of sensory stimulation. Stimulation was provided across a range of frequencies from 70 to 110% in a 
counterbalanced way, in 10% increments–decrements, with 100% defined as the unaided FW cadence of 
each patient. Two types of stimulus were used, one visual and one auditory (see below). 
The FW-cadence was selected as a reference instead of the PW-cadence as this second option would 
have required setting frequencies above and below the PW-cadence, augmenting the number of tests 
required. Since the number of conditions that could be tested was limited by the duration of the 
medication effects, we would be more likely to miss important frequencies if the PW-cadence were used 
as a reference. FW-cadence has also been shown to be similar between PD and control subjects (Morris et 
al. 1994a), making the use of this measurement more appealing. 
The instruction given to the subject was “Walk to the end of the corridor matching the rhythm of the 
stimuli, executing one step per stimulus”. 
Patients did not expect to obtain any direct and immediate benefit from this experiment as it was 
considered a system to evaluate gait. 
Subjects rested seated for 2.5 min between conditions. 
Apparatus 
The system used to record the data consisted of a series of footswitches worn as insoles in the shoes. 
The footswitches were connected by means of fine wires to a radio-transmitter attached to the subjects’ 
belt. Prior to testing the subjects were asked to move around the room freely, habituating them to the 
equipment and the environment, while also checking data transmission. Data (sampled at 1 kHz.) were 
sent via radio to a receiver unit connected to the computer. This configuration allowed the stride cycle 
time to be registered. 
Two photocells, placed 25 m apart, were connected to the recording system so that the recording 
commenced and terminated when the subjects crossed these at the beginning and at the end of the 
walkway. A 2D video-analysis of walking was performed by means of software implemented in MatLab 
6.0. A Canon-XL1 Camcorder was used at a frame-rate of 25 frames/s (sufficient to get 2–3 double-
support phase frames), which was attached to a 25 m-travelling system that moved parallel to the 
walkway. In this way, a video recording was made along the entire walkway, the analysis of which was 
aided by placing reflective markers at the tip and the heel of each shoe. 
To assess the effects of sensory stimulation, the same apparatus was used with the addition of a 
portable in-house device to provide stimulation. Auditory stimulation was provided by means of 
headphones. The sound was a tone with wave-frequency of 4,625 Hz, and intensity was adjusted to be 
clearly perceived by the subjects without being annoying. Visual stimulation was provided by 2 LED’s 
integrated into the subject’s glasses, so that stimulation is perceived in the peripheral visual field. The 
LED’s were 3 mm in diameter with a luminance of 50 mcd/m2. The stimuli were delivered in pulses of 
50 ms and the inter-pulse duration was customized to obtain the desired stimulation frequency. In the case 
of auditory–visual stimulation both stimuli were set in-phase and at the same frequency. 
Kinematic variables 
The variables analysed in the study were: 
Cadence—obtained from footswitch data and expressed as steps/min; 
Step amplitude—calculated from the 2D analysis (when gait was characterised and the effect of 
stimulation at a frequency matching PW-cadence was assessed); and from the distance walked and the 
number of steps necessary to cover the distance when assessing the effect of using different stimulation 
frequencies, expressed in m; 
Velocity—calculated as the product of the step amplitude and cadence, and expressed as m/min; 
CVstride-time—calculated as a % from the footswitch data and defined as (1); 
CVstep-amplitude—calculated as a % from the length of each step and defined as (1) (not applicable when 
studying the effect of stimuli at frequencies different from PW-cadence).  
CV(%)=(SD/mean)×100 (1) 
Statistical analysis 
The student’s t test for independent samples was used to analyse the differences between PD and 
controls for each variable. To assess differences as a function of disease severity one-way ANOVA was 
performed for each variable, and group was the factor considered (PDI–II, PDIII–IV, and controls). The 
normality of distribution was checked by K-S and the equality of variance by Levene’s test. To analyze 
the effects of stimulation at a frequency matching PW-cadence, repeated measures ANOVA (ANOVA-
RM) was calculated for each kinematic variable. One within-subject factor was established (cue) with 
four levels: no cue, auditory cue, visual cue, and auditory–visual cue. Additionally, one between-subject 
factor was set, the group. 
To analyze the effect of different stimulation frequencies ANOVA-RM was calculated for each 
kinematic variable and for each type of stimulation (auditory or visual). One within-subjects factor was 
set (frequency) with six levels: no cue (i.e. PW), and 70, 80, 90, 100, and 110% of FW-cadence. One 
between-subjects factor was set, the group. Pairwise comparisons were only performed with the Controls, 
since the object of the study was to determine if there were frequencies at which gait induced by 
stimulation improved kinematic parameters with respect to the PW. 
In order to analyse how cadence was modulated as a function of frequency and stimulation varieties 
an ANOVA-RM was calculated. Two within-subjects factors were used, one (frequency) with five levels: 
70, 80, 90, 100, and 110%; and the other (Cue) with two levels: auditory (cadence in presence of auditory 
stimulation), and visual (cadence in presence of visual stimulation). The between-subjects factor was the 
group. 
Results 
Gait patterns: patients vs. controls 
The kinematic variables measured were compared between the PD patients and the control subjects 
(Table 3). While there was no difference in the cadence between the groups walking at PW, the PD 
patients walked with shorter step amplitude (t(32.92) = 3.003; P = 0.005) and a reduced velocity 
(t(29.95) = 2.160; P = 0.039) when compared with the controls. Furthermore, there was more variability 
in the walking pattern of PD patients than in controls, expressed as CVstride-time (t(26.34) = 2.575; 
P = 0.016). However, the CVstep-amplitude at their PW was no different between patients and controls.  
When the PD patients were analysed taking into account the severity of their disease (Table 4), one-
way ANOVA showed a main effect of factor group for amplitude (F(2,32) = 13.154; P ≤ 0.001), velocity 
(F(2,32) = 8.966; P = 0.001), CVstride-time (F(2,32) = 13.477; P ≤ 0.001), and CVstep-amplitude 
(F(2,32) = 11.410; P ≤ 0.001); conversely the effect of factor group for cadence did not show 
significance.  
Table 3. Kinematic parameters for PD and Controls individuals 
 PD Controls Significance 
    
Cadence (steps/min) 114.62 (±13.58) 113.73 (±14.58) n.s. 
Step amplitude (m) 0.54 (±0.17) 0.65 (±0.06) P = 0.005 
Velocity (m/min) 61.93 (±23.62) 75.28 (±12.58) P = 0.039 
CV (%) of stride time 4.81 (±4.69) 2.33 (±0.67) P = 0.016 
CV (%) step amplitude. 6.61 (±4.88) 3.92 (±1.41) n.s. 
    
 
Table 4. Kinematic parameters for PDI–II , PDIII–IV and control subjects 
 PDI–II 
 
PDIII–IV 
Controls 
  vs. controls significance 
 vs. PDI–II  
significance  
vs. controls 
significance 
        
Cadence (steps/min) 115.63 (±14.84) n.s.  n.s. 110.34 (±14.31) n.s. 114.62 (±13.58) 
Step amplitude (m) 0.62 (±0.12) n.s.  P ≤ 0.001 0.40 (±0.16) P ≤ 0.001 0.66 (±0.06) 
Velocity (m/min) 72.00 (±20.19) n.s.  P ≤ 0.001 44.03 (±18.61) P ≤ 0.001 75.28 (±12.58) 
CV (%) of stride Time 2.59 (±1.47) n.s.  P ≤ 0.001 8.77 (±5.88) P ≤ 0.001 2.33 (±0.67) 
CV (%) step amplitude 4.41 (±1.99) n.s.  P ≤ 0.001 10.52 (±6.09) P ≤ 0.001 3.92 (±1.41) 
        
 
Pairwise comparisons showed there were no significant differences between PDI–II and controls in any 
of the variables analysed. 
Conversely, compared to the controls, there was a reduction in step amplitude and velocity in the more 
severe PDIII–IV patients; additionally PDIII–IV displayed higher CVstride-time and a higher CVstep-amplitude 
(P ≤ 0.001 for each). 
We assessed the differences in the variables measured between the two different groups of PD 
patients. PDIII–IV patients took shorter steps and walked slower than PDI–II patients; finally, the CVstride-time 
and the CVstep-amplitude were higher in severe PDIII–IV patients than in milder PDI–II patients (P ≤ 0.001 for 
each). 
Stimulation conditions 
Stimulation at a frequency matching PW-cadence 
The effects of sensory stimulation on the kinematics variables of gait were assessed (Table 5).  
Table 5. Effect of sensory stimulation on kinematic parameters of gait in PDIII–IV and control subjects 
  
PW PWA PWV PWAV 
      
PDIII–IV Cadence (steps/min) 110.34 (±14.31) 108.53* (±11.30) 104.74* (±11.06) 104.79*** (±12.04) 
Step amplitude (m) 0.40 (±0.16) 0.45** (±0.15) 0.41 (±0.16) 0.44* (±0.17) 
Velocity (m/min) 44.03 (±18.61) 49.32 (±18.81) 43.17 (±18.38) 46.58 (±20.84) 
CV (%) stride time 8.77 (±5.88) 5.56** (±3.34) 8.40 (±5.90) 4.93* (±3.24) 
CV (%) step amplitude 10.52 (±6.09) 8.54 (±3.86) 11.14 (±5.48) 10.87 (±9.76) 
Controls Cadence (steps/min) 114.56 (±14.40) 110.45* (±13.13) 111.19* (±13.79) 107.54*** (±13.90) 
Step amplitude (m) 0.65 (±0.07) 0.69** (±0.08) 0.67 (±0.10) 0.68* (±0.09) 
Velocity (m/min) 75.01 (±13.31) 76.21 (±14.06) 74.93 (±14.58) 73.72 (±14.02) 
CV (%) stride time 2.33 (±0.71) 2.45 (±0.80) 3.41 (±1.59) 2.71 (±1.89) 
CV(%) step amplitude 4.05 (±1.43) 4.23 (±1.59) 4.78 (±1.12) 4.54 (±0.95) 
      
 
* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001 with respect to PW  
Cadence 
ANOVA-RM indicated a significant effect of the cue (F(3,48) = 5.381; P = 0.003) that affected both 
groups in the same way (since the cue × group interaction was not significant); there were no differences 
between the two groups. Post hoc analysis indicated that all possible variations of the cue reduced 
cadence PW vs. PWA (P = 0.047); PW vs. PWV (P = 0.022); and PW vs. PWAV (P = 0.001). 
Differences between stimulation varieties yielded significant higher cadence at PWA vs. PWAW 
(P = 0.024). 
Amplitude 
ANOVA-RM analysis demonstrated a significant effect of the cue on the amplitude 
(F(1.95,31.29) = 4.691; P = 0.017), which affected the same way both groups, (since, as with cadence, the 
cue × group interaction was not significant); the two groups were different (F(1,16) = 18.071; P = 0.001). 
Post hoc analysis indicated that the step amplitude increased in the presence of auditory and auditory-
visual stimulation for both groups: PW vs. PWA (P = 0.009); and PW vs. PWAV (P = 0.037). After 
analysing the differences between each possible stimulation, it was found that PWA produced larger steps 
than PWV (P = 0.01), while there was a tendency for PWAV to produce a larger step than PWV, although 
this was not significant (P = 0.055). 
Velocity 
In terms of the speed at which the subjects walked, the ANOVA-RM showed a significant effect of 
the factor cue (F(3,48) = 3.395; P = 0.048) on velocity, affecting both groups in the same way (again, no 
significant cue × group interaction), and displaying difference between the groups (F(1,16) = 14.694; 
P = 0.001). Post hoc analysis did not yield any differences between PW and any type of stimulation. It is 
also noteworthy that the auditory stimulation induced faster walking than visual and auditory-visual 
stimulation; PWA vs. PWV (P = 0.022), PWA vs. PWAV (P = 0.027). 
CV of stride time and of step amplitude 
In terms of the CVstride-time, the ANOVA-RM showed the cue had a significant effect (F(3,14) = 7.383; 
P = 0.003), which affected both groups differently as reflected by a significant cue × group interaction 
(F(3,14) = 5.022; P = 0.014). Both groups were different (F(1,16) = 11.861; P = 0.003) and a pairwise 
comparison showed that there was a reduction in the CVstride-time in the PDIII–IV patients in the presence of 
auditory (P = 0.005) and auditory–visual (P = 0.014) stimuli with respect to PW. In contrast, no 
differences were seen in the control subjects. Furthermore, when the differences between the types of 
stimulation on the patients were analysed, there were differences between PWA vs. PWV (P = 0.034), 
and PWAV vs. PWV (P = 0.006), as the CVstride-time was higher in PWV in both cases. 
In contrast, for CVstep-amplitude no significant effect was seen for the cue factor and a difference was 
observed between the groups (F(1,16) = 8.730; P = 0.009). 
Stimulation at different frequencies 
Unstimulated performance: normalization considerations 
There was no difference in the FW-cadence between controls (136.71 ± 13.75) and PDIII–IV patients 
(123.93 ± 12.84) (t(16) = 2.038; P > 0.05), this measure being used as the reference (100%) to set the 
stimulation frequencies; neither in the percentage of FW-cadence corresponding to PW-cadence for each 
group (t(16) = 1.196; P > 0.05; 89.12% ± 7.66 for PDIII–IV, and 84.15% ± 9.81 for controls).  
Stimulation conditions 
Cadence 
ANOVA-RM analysis for auditory stimulation showed a main effect of the factor frequency on the 
cadence (F(2.37,37.98) = 84.556; P ≤ 0.001), affecting both groups similarly (there was no 
frequency × group interaction (F(2.37,37.98) = 1.125; P = 0.343); and no difference between the groups 
(F(1,16) = 3.94; P = 0.064). Pairwise comparisons showed that there were differences between the PW 
and most of the stimulation frequencies (P ≤ 0.001), (except 90%; P = 0.910, Table 6).  
Table 6. Effect of auditory stimulation at different frequencies on kinematic parameters of gait in PDIII–IV patients and control 
subjects 
 
 PW 70% 80% 90% 100% 110% 
        
Cadence 
(steps/min) 
PDIII–IV 110.34 
(±14.31) 
91.13*** 
(±12.65) 
97.76*** 
(±10.91) 
107.82 
(±10.33) 
118.01*** 
(±9.93) 
125.96*** 
(±10.54) 
Controls 114.56 
(±14.40) 
98.17*** 
(±6.03) 
108.00*** 
(±7.54) 
117.72 
(±9.89) 
130.61*** 
(±13.48) 
137.74*** 
(±13.99) 
Step length 
(m.) 
PDIII–IV 0.41 (±0.16) 0.48 (±0.15) 0.53** (±0.14) 
0.53** 
(±0.14) 
0.50*** 
(±0.15) 0.54** (±0.17) 
Controls 0.68 (±0.06) 0.69 (±0.08) 0.72** (±0.09) 
0.71** 
(±0.08) 
0.78*** 
(±0.10) 0.77** (±0.13) 
Velocity 
(m/min) 
PDIII–IV 45.65 
(±19.85) 
42.68 
(±12.32) 
51.90 
(±12.89) 
56.63* 
(±14.99) 
58.94*** 
(±18.76) 
67.88*** 
(±22.82) 
Controls 77.62 
(±13.31) 68.61 (±9.36) 
77.93 
(±12.40) 
84.71* 
(±13.27) 
103.27*** 
(±21.96) 
106.58*** 
(±25.64) 
CV stride time 
(%) 
PDIII–IV 8.77 (±5.88) 4.63 (±2.49) 11.79 (±10.93) 
4.59* 
(±3.86) 3.56** (±3.46) 7.12 (±7.42) 
Controls 2.33 (±0.71) 3.70 (±2.25) 3.09 (±1.70) 2.06* (±0.61) 2.21** (±1.19) 3.69 (±2.84) 
        
 
* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001 with respect to PW 
In contrast, the frequency of visual stimulation (F(2.81,44.99) = 9.097; P ≤ 0.001) affected groups 
differently, as there was a significant interaction between frequency × group (F(2.81,44.99) = 3.583; 
P = 0.023). No differences were manifest between groups (F(1,16) = 0.391; P = 0.541). Since the groups 
did not differ, but there was a frequency × group interaction, each group was analysed separately. There 
was no effect of the frequency of this stimulation on cadence in PDIII–IV patients (F(5,40) = 2.835; 
P = 0.167). Conversely, in the control subjects the frequency affected cadence (F(2.68, 21.48) = 11.326; 
P ≤ 0.001) and a post hoc analysis indicated significant differences between PW and 110% (P = 0.027), 
PW and 100% (P = 0.025), and PW and 70% (P = 0.022; Table 7). 
Amplitude 
The ANOVA-RM indicated that the frequency of auditory stimulation affected step amplitude 
(F(2.88,46.22) = 9.122; P ≤ 0.001), which affected both groups similarly, again there being no 
frequency × group interaction (F(2.88,46.22) = 2.227; P = 0.100). Differences between the groups were 
evident (F(1,16) = 16.972; P = 0.001) and the post hoc analysis indicated an increase of amplitude at the 
frequencies of 80% (P = 0.003), 90% (P = 0.002), 100% (P ≤ 0.001), and 110% (P = 0.002) (Table 6). 
An effect of the frequency of the visual stimulus on step amplitude was also detected 
(F(5,80) = 3.543; P = 0.034), and there was no frequency × group interaction (F(5,80) = 0.356; 
P = 0.868); the two groups differed (F(1,16) = 18.939; P ≤ 0.001). Post hoc analysis indicated that the 
subjects increased their amplitude at all frequencies tested except 70% (110%, P = 0.001; 100%, 
P = 0.003; 90%, P = 0.004, and 80%, P = 0.004; Table 7).  
Velocity 
ANOVA-RM showed that the auditory frequency affected velocity (F(2.30, 36.80) = 29.420; 
P ≤ 0.001) and this effect was similar for both patients and Controls in both groups since there was no 
frequency × group interaction (F(2.30, 36.80) = 2.883; P = 0.062). These groups differed in their 
responses (F(1,16) = 21.455; P ≤ 0.001) and the post hoc analysis indicated differences between PW and 
frequencies: 110% (P ≤ 0.001), 100% (P ≤ 0.001), and 90% (P = 0.014) (Table 6). 
An effect of the frequency of the visual stimulation on velocity (F(3.25,52.07) = 8.254; P ≤ 0.001) 
was observed, but not a frequency × group interaction (F(3.25,52.07) = 1.597; P = 0.198). There were 
different responses in each group (F(1,16) = 19.885; P ≤ 0.001) and post hoc analysis showed differences 
between PW and the frequencies of 110% (P ≤ 0.001), 100% (P = 0.002), 90% (P = 0.01), and 80% 
(P = 0.025) (Table 7). 
Table 7. Effect of visual stimulation at different frequencies on kinematic parameters of gait in PDIII–IV patients and controls 
subjects 
 
 PW 70% 80% 90% 100% 110% 
        
Cadence 
(steps/min) 
PDIII–IV 110.34 
(±14.31) 
111.63 
(±16.84) 
114.30 
(±11.15) 
116.44 
(±12.14) 113.86 (±8.61) 
119.86 
(±11.03) 
Controls 114.56 
(±14.40) 
103.21* 
(±8.95) 
114.34 
(±12.62) 
119.41 
(±12.92) 
126.96* 
(±12.69) 
126.02* 
(±12.51) 
Step length 
(m.) 
PDIII–IV 0.41 (±0.16) 0.48 (±0.14) 0.49** (±0.16) 
0.51** 
(±0.16) 0.48** (±0.14) 
0.50*** 
(±0.15) 
Controls 0.68 (±0.06) 0.69 (±0.07) 0.73** (±0.09) 
0.74** 
(±0.10) 0.73** (±0.11) 
0.77*** 
(±0.14) 
Velocity 
(m/min) 
PDIII–IV 45.65 
(±19.85) 
52.84 
(±15.83) 
55.37* 
(±14.63) 
58.61** 
(±16.68) 
55.12** 
(±17.48) 
59.58*** 
(±17.40) 
Controls 77.62 
(±13.31) 
75.09 
(±17.15) 
85.02* 
(±15.25) 
89.16** 
(±16.71) 
92.77** 
(±19.57) 
96.17*** 
(±20.95) 
CV stride time 
(%) 
PDIII–IV 8.77 (±5.88) 5.05 (±2.36) 5.33 (±4.36) 3.72 (±2.49) 4.23 (±2.40) 5.26 (±3.73) 
Controls 2.33 (±0.71) 4.06 (±1.42) 3.37 (±2.74) 4.21 (±4.06) 2.43 (±0.91) 3.33 (±2.55) 
        
 
* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001 with respect to PW 
CV of stride time 
The different frequencies of the auditory stimulus affected the CVstride-time (F(5,80) = 3.546; 
P = 0.034), in the same way in both groups (no frequency × group interaction, (F(5,80) = 2.817; 
P = 0.066)). The groups were different (F(1,16) = 11.314; P = 0.004); and post hoc analysis showed a 
reduction in CVstride-time with respect to the PW for frequencies of 100% (P = 0.008), and 90% (P = 0.042, 
Table 6). 
The frequency of visual stimulation did not yield any effect on the CVstride-time (F(5,80) = 1.614; 
P = 0.230), and the groups were different (F(1,16) = 4.533; P = 0.049, Table 7). 
Modulation of cadence in presence of stimulation 
When modulation of cadence in presence of the stimuli was analysed, the ANOVA showed a main 
effect of factor frequency (F(1.82,29.17) = 76.827; P ≤ 0.001), as well as significant interaction 
frequency × group (F(1.82,29,17) = 4.322; P = 0.026). A main effect for factor cue was also seen 
(F(1,16) = 6.699; P = 0.020), as well as significant interactions cue × group (F = (1,16) = 8.681; 
P = 0.009). Groups did not differ (F = (1,16) = 2.088; P = 0.168). 
For the PDIII–IV a main effect for factor frequency was seen (F(1.70,13.67) = 23.197; P ≤ 0.001), as 
well as for factor cue (F(1,8) = 15.093; P = 0.005), and interaction cue × frequency (F(4,32) = 20.555; 
P ≤ 0.001), indicating a different performance in presence of both auditory and visual stimulation (Fig. 1). 
Conversely, for controls, a main effect for factor frequency (F(1.84,14.76) = 59.935; P ≤ 0.001) was seen, 
but not for factor cue (F(1,8) = 0.065; P = 0.805), indicating a lack of difference regarding stimulation 
variety (Fig. 1).   
 
 
 
Fig. 1. Cadence induced by auditory (dotted line) and visual (solid line) stimulation in the presence 
of different stimulation frequencies in PDIII–IV patients (a), and in controls (b) 
 
Discussion 
Characterization of gait patterns 
As expected, our results showed that PD patients display an abnormal walking pattern involving 
shorter steps and slower velocity. The pattern of walking in PD patients is more variable than that of the 
control subjects, as reflected by the higher CVstride-time. However, when we broke down our group of 
patients in order to analyse them as a function of disease development, some interesting findings 
appeared. Firstly, no differences were detected in any of the variables between PDI–II and control 
subjects. This indicates that the differences in the step length, velocity, and CVstride-time between PD 
patients and control subjects can be attributed to the alterations in the PDIII–IV group. Indeed, these 
variables were significantly altered in the PD patients when the analysis was carried out between PDIII–IV 
and controls. In addition, the CVstep-amplitude also differed between the PDIII–IV and control subjects. It is 
also noteworthy that the cadence remained the same in patients and control subjects, regardless of 
whether all the patients were analysed together, or whether they were considered in separate groups. This 
confirms previous studies in which cadence has been shown not to be altered in PD (Morris et 
al. 1994a, 1998). 
On the other hand, our results confirm that there are significant alterations in walking as the disease 
progresses, demonstrating differences between PDI–II and PDIII–IV in terms of step amplitude, velocity, 
CVstride-time, and CVstep-amplitude. This particular issue may be important when considering previous studies 
in which no distinction was made in the disease state within the “patient” sample. This is also important 
when contemplating studies that have assessed how sensory stimulation might aid gait in PD. 
In our study, step amplitude and velocity were reduced in PD patients when compared to control 
subjects, in agreement with previous publications (Blin et al. 1990; Morris et al. 1994a, 1996, 2005; 
Thaut et al. 1996; Azulay et al. 1999; Ebersbach et al. 1999; Lewis et al. 2000; Fernández del Olmo and 
Cudeiro 2005; Rochester et al. 2005; Willems et al. 2006). This difference was attributed to the PDIII–IV 
patients, since no differences were manifested between PDI–II and control subjects, in contrast to a 
reduction in step length in early PD as described previously (Ebersbach et al. 1999). The reduction in 
velocity in PD patients as a whole and in the PDIII–IV group was the product of the shorter step amplitude, 
as cadence was no different between any of the patients and control subjects, in accordance with previous 
data (Morris et al. 1994a, 1996, 1998). 
Our results regarding the CVstride-time confirm previous studies showing that this parameter augments 
in PD patients (Hausdorff et al. 1998; Fernández del Olmo and Cudeiro 2005). The failure to identify 
differences in this variable between patients and control subjects in an earlier study may reflect the 
influence of early PD in that sample (Ebersbach et al. 1999). Furthermore, a recent association was 
reported between CVstride-time and falls (Schaafsma et al. 2003), and falling normally occurs in the more 
advanced stages of PD where the highest CVstride-time values were recorded in our study. Analysing the PD 
group as a function of disease development also identified an alteration in the CVstep-amplitude in the PDIII–IV 
patients, which was not detected when the PD patients were considered as a single group. Indeed, the fact 
that the CVstep-amplitude value does not differ from control values in PDI–II patients is in accordance with 
previous work (Ebersbach et al. 1999). 
Effect of sensory stimulation on gait 
The results obtained when the effects of sensory stimuli were analysed indicate that sensory 
stimulation affects similarly to PDIII–IV and controls, with the exception of CVstride-time which was reduced 
only for PDIII–IV if auditory or visual stimulation were employed. This means that auditory stimulation at 
a frequency matching the PW-cadence is effective in facilitating walking in PDIII–IV patients. The increase 
observed in step amplitude is important because amplitude is the variable characteristically impaired in 
PD. Furthermore, the decrease in CVstride-time might reduce the risk of falling, as CVstride-time and the 
number of falls are associated (Schaafsma et al. 2003). It is also noticeable that sensory stimulation of any 
kind reduced the step cadence, both in PDIII–IV and in control subjects. 
Our results concerning step amplitude are in line with previous studies that indicate a positive effect of 
auditory stimulation in PD, producing an increase in amplitude (Enzensberger and Fischer 1996; 
McIntosh et al. 1997). However, these studies often employ stimulation frequencies faster than baseline, 
so that the effect on amplitude may not only be attributed solely to the stimulation itself, but also to its 
frequency. Fewer studies have looked at the influence of stimulation that matches the PW-cadence and 
among these increases in step amplitude are not always observed (Rochester et al. 2005; Willems et 
al. 2006), although in the study carried out by Rochester et al. (2005) no explanation was offered as to 
why the velocity in the PD group given auditory stimulation was not equal to the reported cadence 
multiplied by the amplitude, perhaps suggesting an underestimation of the amplitude. 
In accordance with earlier studies, visual stimulation of the type employed here did not change step 
amplitude (Rochester et al. 2005), although there have been some reports of an increase in stride 
amplitude in presence of visual stimuli (Morris et al. 1994a, 1996, 2005; Azulay et al. 1999; Lewis et 
al. 2000; Suteerawattananon et al. 2004). Notably, spatial visual stimuli were used in these latter studies 
(e.g. stripes laid out on the floor) whereas our visual stimuli were temporal visual stimuli (flashing 
LED’s). This methodological difference probably accounts for the differences in the results observed. 
Cadence was reduced by the presence of sensory stimulation in both groups and this reduction was 
observed across the three types of sensory stimuli tested. Conversely, auditory stimulation at this 
frequency increases cadence in PD patients (Freedland et al. 2002; Willems et al. 2006) and in control 
subjects (Willems et al. 2006). 
Stimulation did not produce a change in velocity, either in PDIII–IV patients or in control subjects, 
velocity reflecting the interaction between cadence and amplitude. The effect of the cues on cadence is 
compensated for by the effect of the cues on amplitude. This failure to observe a change in velocity is in 
agreement with previous studies using auditory stimulation (Freedland et al. 2002; Rochester et al. 2005; 
Willems et al. 2006). When simultaneous auditory–visual stimulation was provided, the effect on step 
amplitude and CVstride-time was similar to that of auditory stimulation alone. There did not seem to be any 
augmentation of the effectiveness of the auditory alone stimulation and it remains the best choice at this 
point, as reported previously from analysing movements in healthy subjects in paradigms other than 
walking (Chen et al. 2002). Indeed, in terms of velocity, the combination of both stimulation varieties led 
to poorer results than auditory alone for both groups. 
Optimization of stimulation frequencies 
Again, the effect of stimulation affected similarly to PDIII–IV and controls in many variables, with the 
exception of cadence in presence of visual stimulation. Willems et al. (2006) have shown similar results 
in presence of auditory stimulation in some variables. Howe et al. (2003) also used a gradient of auditory 
stimuli but their study was lacking of control group. 
The analysis of the uses of different stimulation frequencies indicates that the frequency to be used in 
order to facilitate gait in PDIII–IV should be equal to the PW-cadence or higher, up to that matching FW-
cadence, but not below the PW-cadence frequency. 
For PDIII–IV patients, the PW-cadence was equivalent to 89% of the FW-cadence. Accordingly, when 
auditory stimulation was set at 90% of the FW-cadence PDIII–IV patients increased their step length and 
reduced CVstride-time, similar to the results with stimulation that matched the PW-cadence. 
Moreover, 90 and 100% auditory stimulation increased the velocity in PDIII–IV patients and controls 
with respect to the PW, which becomes very important due to the slow velocity of PD patient at these 
stages. The 110% auditory stimulation increased step length and velocity in PDIII–IV patients and controls, 
but did not alter CVstride-time. Similarly, 80% auditory stimulation also induced larger steps in both groups, 
although this frequency was the only one that might increase CVstride-time (although not significantly) in 
PDIII–IV. As CVstride-time has been positively associated with falls in PD (Schaafsma et al. 2003) we do not 
recommend the use of this frequency, in contrast to other studies (Willems et al. 2006). 
Application of a range of auditory stimuli to a group of PD patients has also been proposed previously 
(Willems et al. 2006). However, surprisingly no comparison was made with PW and thus, no conclusions 
can be drawn regarding the facilitatory effect that auditory stimulation might have on the impaired PW in 
PD patients. 
Cadence was modulated differently depending on the kind of stimulation. Auditory stimulation led to 
an increase in cadence with respect to the PW at higher frequencies (100 and 110%). However, when the 
frequency was slow (80 and 70%) the cadence was lower than the PW in both groups. Since the 90% 
frequency was close to the PW-cadence it did not change the cadence with regards PW. Conversely, no 
frequency of visual stimulation altered the cadence with regard to the PW for the PDIII–IV patients. This 
behaviour was not so marked in the control subjects, whose cadence increased with faster stimulation 
frequencies (100 and 110%) and diminished at 70%. As indicated previously for movements other than 
walking (Chen et al. 2002), this suggests a more powerful interaction between motor and auditory 
systems than motor and visual systems. This different interaction seems to be enhanced in PD patients, 
and it is confirmed by the fact that the cue factor is significant in PDIII–IV patients when comparing the 
performance of cadence with the auditory and visual frequencies proposed. This must be taken into 
account when interpreting other variables dependent on cadence such as velocity. At low frequency 
stimulation, the velocity might be faster with visual cues rather than auditory stimulation. However, this 
may not reflect a better facilitation of the visual stimuli but rather a poorer adaptation to the frequency 
proposed. Unfortunately, there is lack of studies using different frequencies of visual stimulation in PD 
patients. However, this is not the case for auditory stimuli where our data regarding the modulation of 
cadence in the presence of different auditory frequencies above and below baseline are in line with those 
of Howe et al. (2003). Auditory frequencies above the PW-cadence (5%) did not modify cadence in PDIII–
IV patients in another study (Enzensberger and Fischer 1996), probably due to the proximity between the 
stimulus frequency and the PW-cadence. This result again fits well with our data, as 90% auditory 
stimulation did not produce a change in cadence in PDIII–IV patients. Other authors have proposed 
auditory stimulation at different frequencies (McIntosh et al. 1997; Suteerawattananon et al. 2004), 
although the interpretation of the results becomes more difficult as the frequencies proposed were 
compared with FW. 
Auditory stimulation, at a frequency of 80, 90, 100 and 110%, induces larger steps in PDIII–IV patients 
and controls with regard to PW. This is important as short-step amplitude is the typical feature of PD 
(Morris et al. 1994a, 1998). The increase in step length at 90% is in line with our results when the 
stimulation provided matched the PW-cadence, where PDIII–IV patients increased their amplitude in the 
presence of auditory stimulation at this frequency (89%). The increment of amplitude at frequencies 
equivalent to 80% in PD has also been found by others (Willems et al. 2006) and an increase in step 
amplitude in PDIII–IV patients was also observed when synchronizing auditory stimuli at a frequency 
slightly above PW-cadence (Enzensberger and Fischer 1996). However, stride length does not appear to 
be modified in the same way in mildly affected PD patients (Howe et al. 2003). Other studies (McIntosh 
et al. 1997; Suteerawattananon et al. 2004) reported contradictory results in step amplitude in the presence 
of auditory stimulation at different frequencies, which could be explained by the amplitude–cadence 
relationship (Morris et al. 1998). However, in these studies the baseline condition was FW, which in our 
opinion is not relevant to the results with respect to the everyday-PW. 
Auditory stimulation at a frequency of 90 and 100% reduced the CVstride-time in PDIII–IV patients and 
controls. The reduction at 90% is in agreement with our results for PDIII–IV in experiments using auditory 
cues at a frequency matching the PW-cadence (89%). Auditory stimulation at 80% (frequency below PW-
cadence) slightly increased CVstride-time in PDIII–IV patients, results that are in line with the increase in this 
variable with stimulation at a frequency 20% slower than PW-cadence (Ebersbach et al. 1999) and other 
similar results (Willems et al. 2006). 
Visual stimulation had no effect on CVstride-time, neither in PDIII–IV patients nor in control subjects. 
Why auditory stimulation modified gait parameters in PDIII–IV patients and controls, especially at 
frequencies matching the PD cadence, is beyond the scope of this study. Previous work from our group 
indicated a higher cerebellar metabolism (using PET) at rest in PD patients following therapy based on 
auditory stimulation at different frequencies (Fernández del Olmo et al. 2006). Moreover, we identified 
changes in kinematic parameters of walking. This is line with Goldberg’s theory, which associates SMA 
with self-paced movements, and PMA to externally triggered movements (Goldberg 1985). According to 
this theory, the use of sensory cues in the execution of movement by PD patients would be translated into 
less involvement of the defective areas. However, this theory would not explain the different behaviour in 
the presence of auditory or visual stimulation. An effect of auditory stimulation on the excitability of 
motoneurons has been demonstrated (Rossignol and Melvill-Jones 1976) and this could account for such 
differences, and might also explain the control’s behaviour. However, more research into the interaction 
between visual and auditory stimulation in the higher structures ruling movement is needed to clarify the 
behaviour shown by PD patients in the presence of visual or auditory stimulation.  
Conclusions 
In summary, this study indicates that while our PDI–II group do not display a significant impairment in 
the kinematic variables, we have studied the PDIII–IV patients presented abnormal step amplitude, 
velocity, CVstride-time, and CVstep-amplitude. We suggest that it is vital to consider the degree of disease 
progression when characterising movement in PD. Sensory stimulation affects similarly to PDIII–IV and 
controls in a number of variables, suggesting that an effect on early PD might also be present. Auditory 
stimulation at a frequency matching PW-cadence is an effective tool, which facilitates improvement in 
gait in advanced PD patients. This kind of stimulation increases step amplitude and reduces CVstride-time, 
which is most important given its relationship to falling. However, visual stimulation at this frequency 
does not appear to have the same influence on the kinematic parameters analysed in this study, but the 
restricted nature of the visual stimulation should be noted (temporally not spatially modulated; fixed to 
head, not retinal location). Together with experiments using different stimulation frequencies we 
conclude that the frequency that should be used ranges from that matching the patient’s cadence in the 
absence of stimulation, up to a frequency matching FW-cadence. This range of auditory frequencies 
increases step length, reduces CVstride-time, and, in the case of frequencies above the PW-cadence, 
augments velocity. In contrast to other studies (Willems et al. 2006), auditory frequencies slower than the 
PW-cadence are not recommended as they increase step length and the CVstride-time, which has been 
associated with falls (Schaafsma et al. 2003). 
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